As we are all aware, the U.S. healthcare system is undergoing tremendous change. In fact, the scope of this overhaul has prompted Jeffrey Bauer, PhD, the well-known healthcare economist and futurist, to proclaim that “More change will occur in healthcare over the next 10 years than has occurred over the past 50.”
Labs need to be prepared for a fundamental shift in reimbursement and a new explosion of technology. In this can’t-miss webinar, former Mayo Medical Laboratories executive Mr. Keith Laughman proposes that chemistry and pathology labs need to borrow from the pharmaceutical industry's PharmacoEconomics and develop our own LabacoEconomics.
This webinar, Part II of the series, will build upon the LabacoEconomics rationale outlined by Mr. Laughman during Part I and provide explicit examples of this strategy at work..
Part I is available on demand on LabLeaders.com.
R. Keith Laughman is an accomplished senior executive with a time-tested record of maximizing efficiency, growth and profitability in both startup and mature healthcare organizations. Currently Mr. Laughman is the Managing Partner with CareTinuum Consulting Partners, LLC, and a Principal with TRG Healthcare Consulting, LLC. Mr. Laughman has served as the President and Executive Director of Mayo Medical Laboratories, President of AmeriPath Esoteric Services & Specialty Laboratories and led the startup of Med Fusion, ClearPoint Diagnostics Laboratory and US Oncology Laboratory.